Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity

Natural killer-dendritic cell cross-talk in cancer immunotherapy

Administration of dendritic cells in cancer nodules in hepatocellular carcinoma

[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]

The immunotherapy of prostate and bladder cancer

Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia